Generic Drugs and GDUFA Reauthorization: In Brief

Research ReportCRS ReportVersion 5

R44703

Generic Drugs and GDUFA Reauthorization: In Brief

Published Jul 5, 2017Updated Jun 20, 2025

Full report

What this is

The Congressional Research Service is a nonpartisan policy and legal analysis arm of the Library of Congress. CRS reports are written for members of Congress and their staff, not the public — but they’re made available openly through Congress.gov.

Read the PDF on Congress.gov

HR 2430115th Congress
FDA Reauthorization Act of 2017
Aug 18, 2017 · Signed by President.
S 934115th Congress
FDA Reauthorization Act of 2017
May 11, 2017 · Placed on Senate Legislative Calendar under General Orders. Calendar No. 76.

Generic Drugs and GDUFA Reauthorization: In Brief

Legislation this report covers